Edwards Lifesciences Corporatio

Historical 13F Holders

Symbol
EW
CUSIP
28176E108
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 1,241 499 M $36.1 B
2024 Q4 1,280 502 M $37.2 B
2024 Q3 1,266 484 M $31.9 B
2024 Q2 1,352 507 M $46.8 B
2024 Q1 1,333 509 M $48.6 B
2023 Q4 1,297 500 M $38.2 B
2023 Q3 1,276 494 M $34.2 B
2023 Q2 1,326 496 M $46.8 B
2023 Q1 1,292 498 M $41.2 B
2022 Q4 1,282 535 M $40.5 B
2022 Q3 1,301 518 M $42.8 B
2022 Q2 1,314 511 M $48.6 B
2022 Q1 1,353 510 M $60.0 B
2021 Q4 1,366 517 M $66.9 B
2021 Q3 1,270 514 M $58.2 B
2021 Q2 1,233 514 M $53.2 B
2021 Q1 1,176 510 M $42.6 B
2020 Q4 1,213 530 M $49.2 B
2020 Q3 1,127 516 M $41.2 B
2020 Q2 1,091 509 M $35.2 B
2020 Q1 1,066 172 M $32.3 B
2019 Q4 1,148 177 M $41.2 B
2019 Q3 1,022 174 M $38.1 B
2019 Q2 987 174 M $32.2 B
2019 Q1 979 176 M $33.6 B
2018 Q4 918 180 M $27.6 B
2018 Q3 905 184 M $32.0 B
2018 Q2 881 178 M $25.9 B
2018 Q1 854 175 M $24.4 B
2017 Q4 813 176 M $19.9 B
2017 Q3 771 177 M $19.3 B
2017 Q2 759 176 M $20.8 B
2017 Q1 728 178 M $16.8 B
2016 Q4 731 182 M $17.1 B
2016 Q3 727 180 M $21.7 B
2016 Q2 730 179 M $18.4 B
2016 Q1 699 186 M $16.0 B
2015 Q4 638 185 M $14.8 B
2015 Q3 597 89.3 M $12.7 B
2015 Q2 605 85.2 M $12.1 B
2015 Q1 597 91.1 M $13.0 B
2014 Q4 587 92.8 M $11.8 B
2014 Q3 522 92.4 M $9.47 B
2014 Q2 452 95.3 M $8.18 B
2014 Q1 443 97.7 M $7.25 B